{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:01:32Z","timestamp":1792317692476,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82000359"],"award-info":[{"award-number":["82000359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-17-0018361 and G-19-0026380"],"award-info":[{"award-number":["G-17-0018361 and G-19-0026380"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiomyocyte death contributes to cardiac pathology of diabetes. Studies have shown that the RIPK3\/MLKL necroptosis signaling is activated in diabetic hearts. Deletion of RIPK3 was reported to attenuate myocardial injury and heart dysfunction in streptozocin (STZ)-induced diabetic mice, suggesting a potential role of necroptosis in diabetic cardiomyopathy. This study characterized cardiomyocyte necroptosis in diabetic hearts and investigated whether MLKL-mediated necroptosis is a target for cardiac protection in diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Type 1 diabetes was induced in RIPK3 knockout, MLKL knockout and wild-type mice. Akita Type-1 diabetic mice were injected with shRNA for MLKL. Myocardial function was assessed by echocardiography. Immuno-histological analyses determined cardiomyocyte death and fibrosis in the heart. Cultured adult mouse cardiomyocytes were incubated with high glucose in the presence of various drugs. Cell death and phosphorylation of RIPK3 and MLKL were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We showed that the levels of phosphorylated RIPK3 and MLKL were higher in high glucose-stimulated cardiomyocytes and hearts of STZ-induced type-1 diabetic mice, akita mice and type-1 diabetic monkeys when compared to non-diabetic controls. Inhibition of RIPK3 by its pharmacological inhibitor or gene deletion, or MLKL deletion prevented high glucose-induced MLKL phosphorylation and attenuated necroptosis in cardiomyocytes. In STZ-induced type-1 diabetic mice, cardiomyocyte necroptosis was present along with elevated cardiac troponin I in serum and MLKL oligomerization, and co-localized with phosphorylated MLKL. Deletion of RIPK3 or MLKL prevented MLKL phosphorylation and cardiac necroptosis, attenuated serum cardiac troponin I levels, reduced myocardial collagen deposition and improved myocardial function in STZ-injected mice. Additionally, shRNA-mediated down-regulation of MLKL reduced cardiomyocyte necroptosis in akita mice. Interestingly, incubation with anti-diabetic drugs (empagliflozin and metformin) prevented phosphorylation of RIPK3 and MLKL, and reduced cell death in high glucose-induced cardiomyocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have provided evidence that cardiomyocyte necroptosis is present in diabetic hearts and that MLKL-mediated cardiomyocyte necroptosis contributes to diabetic cardiomyopathy. These findings highlight MLKL-mediated necroptosis as a target for cardiac protection in diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-022-01602-9","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T12:02:59Z","timestamp":1661601779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes"],"prefix":"10.1186","volume":"21","author":[{"given":"Ting","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangneng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Chang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"issue":"19","key":"1602_CR1","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035\u20138.","journal-title":"JAMA"},{"issue":"2","key":"1602_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2337\/diab.23.2.105","volume":"23","author":"MJ Garcia","year":"1974","unstructured":"Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974;23(2):105\u201311.","journal-title":"Diabetes"},{"issue":"8","key":"1602_CR3","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","volume":"27","author":"GA Nichols","year":"2004","unstructured":"Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27(8):1879\u201384.","journal-title":"Diabetes Care"},{"issue":"2","key":"1602_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1373\/clinchem.2010.149740","volume":"57","author":"WB Kannel","year":"2011","unstructured":"Kannel WB. Framingham study insights on diabetes and cardiovascular disease. Clin Chem. 2011;57(2):338\u20139.","journal-title":"Clin Chem"},{"issue":"25","key":"1602_CR5","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213\u201323.","journal-title":"Circulation"},{"issue":"1","key":"1602_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2021.08.026","volume":"12","author":"J Wei","year":"2022","unstructured":"Wei J, Zhao Y, Liang H, Du W, Wang L. Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy. Acta Pharm Sin B. 2022;12(1):1\u201317.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"1602_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99(4):1765\u2013817.","journal-title":"Physiol Rev"},{"issue":"1","key":"1602_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/cvr\/cvp189","volume":"84","author":"Y Li","year":"2009","unstructured":"Li Y, Feng Q, Arnold M, Peng T. Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. Cardiovasc Res. 2009;84(1):100\u201310.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"1602_CR9","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2337\/db08-0617","volume":"58","author":"E Shen","year":"2009","unstructured":"Shen E, Li Y, Shan L, Zhu H, Feng Q, Arnold JM, Peng T. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes. 2009;58(10):2386\u201395.","journal-title":"Diabetes"},{"key":"1602_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.430","volume":"5","author":"X Li","year":"2014","unstructured":"Li X, Du N, Zhang Q, Li J, Chen X, Liu X, Hu Y, Qin W, Shen N, Xu C, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014;5: e1479.","journal-title":"Cell Death Dis"},{"issue":"8","key":"1602_CR11","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00125-015-3622-8","volume":"58","author":"D Zheng","year":"2015","unstructured":"Zheng D, Ma J, Yu Y, Li M, Ni R, Wang G, Chen R, Li J, Fan GC, Lacefield JC, et al. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL\/6 mice. Diabetologia. 2015;58(8):1949\u201358.","journal-title":"Diabetologia"},{"issue":"7","key":"1602_CR12","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00394-015-1034-7","volume":"55","author":"HC Hsu","year":"2016","unstructured":"Hsu HC, Chen CY, Lee BC, Chen MF. High-fat diet induces cardiomyocyte apoptosis via the inhibition of autophagy. Eur J Nutr. 2016;55(7):2245\u201354.","journal-title":"Eur J Nutr"},{"issue":"11","key":"1602_CR13","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.bbadis.2016.08.005","volume":"1862","author":"S Li","year":"2016","unstructured":"Li S, Zhang L, Ni R, Cao T, Zheng D, Xiong S, Greer PA, Fan GC, Peng T. Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress. Biochim Biophys Acta. 2016;1862(11):2023\u201333.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1602_CR14","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Qin Y, Lv J, Wang Y, Che H, Chen X, Jiang Y, Li A, Sun X, Yue E, et al. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 2018;9(10):1000.","journal-title":"Cell Death Dis"},{"issue":"12","key":"1602_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/antiox8120638","volume":"8","author":"S Kar","year":"2019","unstructured":"Kar S, Shahshahan HR, Hackfort BT, Yadav SK, Yadav R, Kambis TN, Lefer DJ, Mishra PK. Exercise training promotes cardiac hydrogen sulfide biosynthesis and mitigates pyroptosis to prevent high-fat diet-induced diabetic cardiomyopathy. Antioxidants (Basel). 2019;8(12):638.","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"1602_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cvr\/cvu146","volume":"103","author":"M Luedde","year":"2014","unstructured":"Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F, et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res. 2014;103(2):206\u201316.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"1602_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.4017","volume":"22","author":"T Zhang","year":"2016","unstructured":"Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, Liu Y, Zheng W, Shang H, Zhang J, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22(2):175\u201382.","journal-title":"Nat Med"},{"issue":"1","key":"1602_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ncb2883","volume":"16","author":"Z Cai","year":"2014","unstructured":"Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu LG, Liu ZG. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol. 2014;16(1):55\u201365.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1602_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/cr.2013.171","volume":"24","author":"X Chen","year":"2014","unstructured":"Chen X, Li W, Ren J, Huang D, He WT, Song Y, Yang C, Zheng X, Chen P, Han J. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014;24(1):105\u201321.","journal-title":"Cell Res"},{"issue":"4","key":"1602_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.celrep.2014.04.026","volume":"7","author":"Y Dondelinger","year":"2014","unstructured":"Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA, Marquis RW, et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 2014;7(4):971\u201381.","journal-title":"Cell Rep"},{"issue":"1","key":"1602_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, Wang FS, Wang X. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014;54(1):133\u201346.","journal-title":"Mol Cell"},{"issue":"3","key":"1602_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1159\/000461391","volume":"41","author":"W Liang","year":"2017","unstructured":"Liang W, Chen M, Zheng D, Li J, Song M, Zhang W, Feng J, Lan J. The opening of ATP-sensitive K+ channels protects H9c2 cardiac cells against the high glucose-induced injury and inflammation by inhibiting the ROS-TLR4-necroptosis pathway. Cell Physiol Biochem. 2017;41(3):1020\u201334.","journal-title":"Cell Physiol Biochem"},{"key":"1602_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bcp.2019.02.022","volume":"163","author":"L Sun","year":"2019","unstructured":"Sun L, Chen Y, Luo H, Xu M, Meng G, Zhang W. Ca(2+)\/calmodulin-dependent protein kinase II regulation by inhibitor 1 of protein phosphatase 1 alleviates necroptosis in high glucose-induced cardiomyocytes injury. Biochem Pharmacol. 2019;163:194\u2013205.","journal-title":"Biochem Pharmacol"},{"key":"1602_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2019.10.416","volume":"146","author":"P Kang","year":"2020","unstructured":"Kang P, Wang J, Fang D, Fang T, Yu Y, Zhang W, Shen L, Li Z, Wang H, Ye H, et al. Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis. Free Radic Biol Med. 2020;146:198\u2013210.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1602_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/JOE-21-0134","volume":"251","author":"N Apaijai","year":"2021","unstructured":"Apaijai N, Jinawong K, Singhanat K, Jaiwongkam T, Kerdphoo S, Chattipakorn SC, Chattipakorn N. Necrostatin-1 reduces cardiac and mitochondrial dysfunction in prediabetic rats. J Endocrinol. 2021;251(1):27\u201339.","journal-title":"J Endocrinol"},{"issue":"2","key":"1602_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","volume":"42","author":"S Song","year":"2021","unstructured":"Song S, Ding Y, Dai GL, Zhang Y, Xu MT, Shen JR, Chen TT, Chen Y, Meng GL. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation. Acta Pharmacol Sin. 2021;42(2):230\u201341.","journal-title":"Acta Pharmacol Sin"},{"key":"1602_CR27","doi-asserted-by":"crossref","first-page":"6617816","DOI":"10.1155\/2021\/6617816","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li X, Hua Y, Ding Y, Meng G, Zhang W. RIPK3-mediated necroptosis in diabetic cardiomyopathy requires CaMKII activation. Oxid Med Cell Longev. 2021;2021:6617816.","journal-title":"Oxid Med Cell Longev"},{"key":"1602_CR28","doi-asserted-by":"publisher","first-page":"6173685","DOI":"10.1155\/2019\/6173685","volume":"2019","author":"L Chang","year":"2019","unstructured":"Chang L, Wang Z, Ma F, Tran B, Zhong R, Xiong Y, Dai T, Wu J, Xin X, Guo W, et al. ZYZ-803 mitigates endoplasmic reticulum stress-related necroptosis after acute myocardial infarction through downregulating the RIP3-CaMKII signaling pathway. Oxid Med Cell Longev. 2019;2019:6173685.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"1602_CR29","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2337\/db09-1800","volume":"59","author":"J Li","year":"2010","unstructured":"Li J, Zhu H, Shen E, Wan L, Arnold JM, Peng T. Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes. Diabetes. 2010;59(8):2033\u201342.","journal-title":"Diabetes"},{"key":"1602_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119963","volume":"285","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhou L, Zhou Y, Wang L, Jiang W, Liu L, Yue S, Zheng P, Liu H. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2\/NFkappaB signaling pathway. Life Sci. 2021;285: 119963.","journal-title":"Life Sci"},{"issue":"7","key":"1602_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1258\/ebm.2010.009361","volume":"235","author":"X Jin","year":"2010","unstructured":"Jin X, Zeng L, He S, Chen Y, Tian B, Mai G, Yang G, Wei L, Zhang Y, Li H, et al. Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys. Exp Biol Med (Maywood). 2010;235(7):877\u201385.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"13","key":"1602_CR32","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1042\/CS20181022","volume":"133","author":"D Zheng","year":"2019","unstructured":"Zheng D, Zhang Y, Zheng M, Cao T, Wang G, Zhang L, Ni R, Brockman J, Zhong H, Fan GC, et al. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity. Clin Sci (Lond). 2019;133(13):1505\u201321.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1602_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2337\/db15-0963","volume":"65","author":"R Ni","year":"2016","unstructured":"Ni R, Zheng D, Xiong S, Hill DJ, Sun T, Gardiner RB, Fan GC, Lu Y, Abel ED, Greer PA, et al. Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type 1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy. Diabetes. 2016;65(1):255\u201368.","journal-title":"Diabetes"},{"issue":"11","key":"1602_CR34","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.2337\/db10-1333","volume":"60","author":"Y Li","year":"2011","unstructured":"Li Y, Ma J, Zhu H, Singh M, Hill D, Greer PA, Arnold JM, Abel ED, Peng T. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes. Diabetes. 2011;60(11):2985\u201394.","journal-title":"Diabetes"},{"issue":"5","key":"1602_CR35","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/CIRCHEARTFAILURE.115.002383","volume":"8","author":"R Ni","year":"2015","unstructured":"Ni R, Zheng D, Wang Q, Yu Y, Chen R, Sun T, Wang W, Fan GC, Greer PA, Gardiner RB, et al. Deletion of capn4 protects the heart against endotoxemic injury by preventing ATP synthase disruption and inhibiting mitochondrial superoxide generation. Circ Heart Fail. 2015;8(5):988\u201396.","journal-title":"Circ Heart Fail"},{"key":"1602_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-4939-8754-2_8","volume":"1857","author":"Z Cai","year":"2018","unstructured":"Cai Z, Liu ZG. Detection of MLKL oligomerization during programmed necrosis. Methods Mol Biol. 2018;1857:85\u201392.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"1602_CR37","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10495-017-1413-z","volume":"22","author":"M Sachet","year":"2017","unstructured":"Sachet M, Liang YY, Oehler R. The immune response to secondary necrotic cells. Apoptosis. 2017;22(10):1189\u2013204.","journal-title":"Apoptosis"},{"issue":"3","key":"1602_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/00325481.2017.1259544","volume":"129","author":"R Devi","year":"2017","unstructured":"Devi R, Mali G, Chakraborty I, Unnikrishnan MK, Abdulsalim S. Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Postgrad Med. 2017;129(3):382\u201392.","journal-title":"Postgrad Med"},{"issue":"2","key":"1602_CR39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s12325-021-01989-z","volume":"39","author":"S Rao","year":"2022","unstructured":"Rao S. Use of sodium-glucose cotransporter-2 inhibitors in clinical practice for heart failure prevention and treatment: beyond type 2 diabetes. A narrative review. Adv Ther. 2022;39(2):845\u201361.","journal-title":"Adv Ther"},{"issue":"4","key":"1602_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ehf2.12336","volume":"5","author":"J Mustroph","year":"2018","unstructured":"Mustroph J, Wagemann O, Lucht CM, Trum M, Hammer KP, Sag CM, Lebek S, Tarnowski D, Reinders J, Perbellini F, et al. Empagliflozin reduces Ca\/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes. ESC Heart Fail. 2018;5(4):642\u20138.","journal-title":"ESC Heart Fail"},{"issue":"3","key":"1602_CR41","first-page":"2807","volume":"18","author":"T Fang","year":"2018","unstructured":"Fang T, Cao R, Wang W, Ye H, Shen L, Li Z, Hu J, Gao Q. Alterations in necroptosis during ALDH2mediated protection against high glucoseinduced H9c2 cardiac cell injury. Mol Med Rep. 2018;18(3):2807\u201315.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1602_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/ijmm.2017.3006","volume":"40","author":"W Liang","year":"2017","unstructured":"Liang W, Chen M, Zheng D, He J, Song M, Mo L, Feng J, Lan J. A novel damage mechanism: contribution of the interaction between necroptosis and ROS to high glucose-induced injury and inflammation in H9c2 cardiac cells. Int J Mol Med. 2017;40(1):201\u20138.","journal-title":"Int J Mol Med"},{"key":"1602_CR43","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.2147\/DMSO.S300388","volume":"14","author":"Q Xu","year":"2021","unstructured":"Xu Q, Tan X, Xian W, Geng J, Li H, Tang B, Zhang H, Wang H, Gao Q, Kang P. Changes of necroptosis in irbesartan medicated cardioprotection in diabetic rats. Diabetes Metab Syndr Obes. 2021;14:3851\u201363.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"1602_CR44","first-page":"730","volume":"2","author":"X Liu","year":"2021","unstructured":"Liu X, Xie X, Ren Y, Shao Z, Zhang N, Li L, Ding X, Zhang L. The role of necroptosis in disease and treatment. MedComm (2020). 2021;2(4):730\u201355.","journal-title":"MedComm (2020)"},{"key":"1602_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113684","volume":"171","author":"X Liu","year":"2020","unstructured":"Liu X, Zhang Y, Gao H, Hou Y, Lu JJ, Feng Y, Xu Q, Liu B, Chen X. Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells. Biochem Pharmacol. 2020;171: 113684.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1602_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.immuni.2017.06.001","volume":"47","author":"S Yoon","year":"2017","unstructured":"Yoon S, Kovalenko A, Bogdanov K, Wallach D. MLKL, the Protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation. Immunity. 2017;47(1):51\u201365.","journal-title":"Immunity"},{"issue":"4","key":"1602_CR47","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/15548627.2021.1954348","volume":"18","author":"Q Zhan","year":"2022","unstructured":"Zhan Q, Jeon J, Li Y, Huang Y, Xiong J, Wang Q, Xu TL, Ji FH, Du G, Zhu MX. CAMK2\/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux. Autophagy. 2022;18(4):726\u201344.","journal-title":"Autophagy"},{"issue":"8","key":"1602_CR48","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41556-019-0356-8","volume":"21","author":"SB Lee","year":"2019","unstructured":"Lee SB, Kim JJ, Han SA, Fan Y, Guo LS, Aziz K, Nowsheen S, Kim SS, Park SY, Luo Q, et al. The AMPK-Parkin axis negatively regulates necroptosis and tumorigenesis by inhibiting the necrosome. Nat Cell Biol. 2019;21(8):940\u201351.","journal-title":"Nat Cell Biol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01602-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01602-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01602-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T14:16:37Z","timestamp":1727878597000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01602-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1602"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01602-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse experimental procedures were approved by the Animal Use Subcommittee at the University of Western Ontario, Canada (protocol number: 2021-054), and Soochow University, China (protocol number: 2017-0043). All rhesus macaque experiments were approved by the Institutional Animal Care and Use Committee of Experimental Animal Center, West China Hospital, Sichuan University, China (protocol number: 2014004A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}